352 related articles for article (PubMed ID: 25724547)
21. Current Pattern of Psychiatric Comorbidity and Psychotropic Drug Prescription in Child and Adolescent Patients.
Araz Altay M; Bozatlı L; Demirci Şipka B; Görker I
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31108992
[No Abstract] [Full Text] [Related]
22. Approved and Off-Label Use of Prescribed Psychotropic Medications among Federal Canadian Inmates.
Brown GP; Stewart LA; Rabinowitz T; Boudreau H; Wright AJ
Can J Psychiatry; 2018 Oct; 63(10):683-691. PubMed ID: 29706116
[TBL] [Abstract][Full Text] [Related]
23. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
24. Experiences with Patient Refusal of Off-Label Prescribing of Psychotropic Medications to Children and Adolescents in Japan.
Tsujii N; Saito T; Izumoto Y; Usami M; Okada T; Negoro H; Iida J
J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):642-5. PubMed ID: 26103533
[TBL] [Abstract][Full Text] [Related]
25. Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital.
Czarniak P; Bint L; Favié L; Parsons R; Hughes J; Sunderland B
PLoS One; 2015; 10(3):e0120630. PubMed ID: 25756896
[TBL] [Abstract][Full Text] [Related]
26. [Off-label prescription of psychopharmacological drugs for children and adolescents].
Pagsberg AK; Thomsen PH
Ugeskr Laeger; 2017 Aug; 179(35):. PubMed ID: 28874238
[TBL] [Abstract][Full Text] [Related]
27. Psychotropic medication use in children and adolescents in an inpatient setting.
Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
[TBL] [Abstract][Full Text] [Related]
28. Prescription Pattern of Antidepressants for Children and Adolescents in Korea Based on Nationwide Data.
Chon MW; Lee J; Chung S; Kim Y; Kim HW
J Korean Med Sci; 2017 Oct; 32(10):1694-1701. PubMed ID: 28875616
[TBL] [Abstract][Full Text] [Related]
29. Pediatric off-label use of psychotropic drugs approved for adult use in Japan in the light of approval information regarding pediatric patients in the United States: a study of a pharmacy prescription database.
Tanemura N; Asawa M; Kuroda M; Sasaki T; Iwane Y; Urushihara H
World J Pediatr; 2019 Feb; 15(1):92-99. PubMed ID: 30506238
[TBL] [Abstract][Full Text] [Related]
30. The prescribing of psychotropic drugs in mental health services in Trinidad.
Moore S; Jaime LK; Maharajh H; Ramtahal I; Reid S; Ramsewak FS; Maharaj M
Rev Panam Salud Publica; 2002 Sep; 12(3):207-14. PubMed ID: 12396640
[TBL] [Abstract][Full Text] [Related]
31. [Prescription of psychotropic drugs off label].
Petrova NN; Semenova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7):130-135. PubMed ID: 37490678
[TBL] [Abstract][Full Text] [Related]
32. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
[TBL] [Abstract][Full Text] [Related]
33. [Off-label prescriptions in acute psychiatry: a practice-based evaluation].
Hoff R; Braam AW
Tijdschr Psychiatr; 2013; 55(4):233-45. PubMed ID: 23595838
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of prescriptions for psychotropic drugs in a psychiatric hospital].
Hida H; Faber M; Alberto-Gondouin MC; Jalaguier E
Therapie; 1997; 52(6):573-8. PubMed ID: 9734110
[TBL] [Abstract][Full Text] [Related]
35. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
Dos Santos L; Heineck I
Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
[TBL] [Abstract][Full Text] [Related]
36. [Off-label drug prescriptions among outpatient children and adolescents in Germany--a database analysis].
Sonntag D; Trebst D; Kiess W; Kapellen T; Bertsche T; Kostev K
Dtsch Med Wochenschr; 2013 Oct; 138(44):2239-45. PubMed ID: 24150699
[TBL] [Abstract][Full Text] [Related]
37. Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young Adults.
Bliddal M; Rasmussen L; Andersen JH; Jensen PB; Pottegård A; Munk-Olsen T; Kildegaard H; Wesselhoeft R
JAMA Psychiatry; 2023 Feb; 80(2):176-180. PubMed ID: 36515919
[TBL] [Abstract][Full Text] [Related]
38. A survey of the off-label use of mood stabilizers in a large psychiatric hospital.
Haw C; Stubbs J
J Psychopharmacol; 2005 Jul; 19(4):402-7. PubMed ID: 15982996
[TBL] [Abstract][Full Text] [Related]
39. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions.
Aagaard L; Hansen EH
Br J Clin Pharmacol; 2011 May; 71(5):751-7. PubMed ID: 21241353
[TBL] [Abstract][Full Text] [Related]
40. [Drug prescriptions study in the outpatient setting: assessment of off-label uses in children].
Blanco-Reina E; Vega-Jiménez MA; Ocaña-Riola R; Márquez-Romero EI; Bellido-Estévez I
Aten Primaria; 2015; 47(6):344-50. PubMed ID: 25443768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
